Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges-Reference-Cited by-同舟云学术

Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges

Published:2020-05-27 Issue:19 Volume:63 Page:10705-10725
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zipfel Pauline¹,Rochais Christophe¹^ORCID,Baranger Kévin²,Rivera Santiago²,Dallemagne Patrick¹^ORCID

Affiliation:

1. Normandie Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032 Caen, France

2. Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France

Funder

Agence Nationale de la Recherche

European Regional Development Fund

Aix-Marseille Universit?

Centre National de la Recherche Scientifique

Association France Alzheimer

R?gion Normandie

Excellence Initiative of Aix-Marseille Universit?

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00352

Reference226 articles.

1. Patterson, C. World Alzheimer Report 2018. The State of the Art of Dementia Research: New Frontiers; London Alzheimer’s Disease International: London, 2018; https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf (accessed 2020-02-08).

2. Is there new hope for therapeutic matrix metalloproteinase inhibition?

3. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors

4. Structure and function of matrix metalloproteinases and TIMPs

5. Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer’s disease;Neurobiology of Aging;2024-09

2. Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease;Current Topics in Medicinal Chemistry;2024-08-20

3. Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming;Science;2024-08-02

4. The role of matrix metalloproteinases in the pathogenetic mechanisms of ischemic stroke;Russian neurological journal;2024-07-23

5. Immunotherapies: A Treasure Trove of Alzheimer's Disease;Current Pharmaceutical Biotechnology;2024-07-19